8 Nov 2022 , 03:57 PM
Net profit of Windlas Biotech rose 46.87% to Rs 12.19 crore in the quarter ended September 2022 as against Rs 8.30 crore during the previous quarter ended September 2021. Sales rose 15.17% to Rs 132.73 crore in the quarter ended September 2022 as against Rs 115.25 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 132.73 | 115.25 | 15 |
| OPM % | 12.09 | 11.41 | – |
| PBDT | 18.54 | 13.94 | 33 |
| PBT | 15.64 | 10.86 | 44 |
| NP | 12.19 | 8.30 | 47 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
